Cargando…
Expression patterns of cluster of differentiation 147 impact the prognosis of hepatocellular carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) has very low overall survival. According to global cancer statistics, approximately 905677 new cases were reported in 2020, with at least 830180 of them being fatal. Cluster of differentiation 147 (CD147) is a novel, transmembrane glycoprotein that is expre...
Autores principales: | Xu, Yun-Ji, He, Hong-Jie, Wu, Peng, Li, Wen-Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473926/ https://www.ncbi.nlm.nih.gov/pubmed/37663949 http://dx.doi.org/10.4251/wjgo.v15.i8.1412 |
Ejemplares similares
-
TMEM147 is a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma
por: Fan, Wen-Jie, et al.
Publicado: (2023) -
Cellular senescence throws new insights into patient classification and pharmacological interventions for clinical management of hepatocellular carcinoma
por: Wang, Hou-Hong, et al.
Publicado: (2023) -
Role of melatonin in the treatment of COVID-19; as an adjuvant through cluster differentiation 147 (CD147)
por: Sehirli, Ahmet Ozer, et al.
Publicado: (2020) -
Exploring the pharmacological mechanism of Wuzhuyu decoction on hepatocellular carcinoma using network pharmacology
por: Ouyang, Jia-Ying, et al.
Publicado: (2023) -
Prognostic and biological role of the N-Myc downstream-regulated gene family in hepatocellular carcinoma
por: Yin, Xin, et al.
Publicado: (2022)